Tag: Q4FY25
Piramal Pharma CDMO growth hit by US policy jitters; recovery seen in FY27 | Company Business News-OxBig News Network
Piramal Pharma anticipates muted, single-digit growth for its contract development and manufacturing organization (CDMO) business in FY26, hurt by near-term uncertainties as clients defer...
Biocon sees mid-teens revenue growth on biosimilars, generics push | Mint
Biocon Ltd expects its overall revenue to grow in mid-teens this financial year, and the company is betting on a robust launch pipeline in...
Vijay Shekhar Sharma forecasts Paytm to turn PAT positive in Q1FY26 | Company Business News
Paytm’s parent One97 Communications Ltd is expected to turn profitable from the ongoing quarter, said its founder and chief executive officer Vijay Shekhar Sharma,...
Private capex stays sluggish in Q4FY25 despite growth in new projects: Report – Times of India-OxBig News Network
This is an AI-generated image, used for representational purposes only. NEW DELHI: Private capital expenditure (capex) in India remained weak in the fourth...
Indian Oils net profit jumps 50% to Rs 7,625 crore in Q4FY25; Rs 3 announced as dividend – The Tribune-OxBig News Network
New Delhi , April 30 (ANI): Indian Oil Corporation Ltd. (IOCL) has registered a net profit of Rs 7,265 crores during the January-March quarter...